Literature DB >> 15659520

Re: Pooled analysis of fluorouracil-based adjuvant therapy of stage II and III colon cancer: who benefits and by how much?

Hany Elsaleh, Barry Iacopetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15659520     DOI： 10.1200/JCO.2005.05.190

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Combining Clinicopathology, IVIM-DWI and Texture Parameters for a Nomogram to Predict Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Authors:  Rixin Su; Shusheng Wu; Hao Shen; Yaolin Chen; Jingya Zhu; Yu Zhang; Haodong Jia; Mengge Li; Wenju Chen; Yifu He; Fei Gao
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

2.  Identifying the long-term survival beneficiary of chemotherapy for stage N1c sigmoid colon cancer.

Authors:  Shan Liu; Yaobin Lin; Sihan Huang; Shufang Xue; Ruoyao Huang; Lu Chen; Chengyi Wang
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.